Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, modest growth trend.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-177.18M
↓ 29% below average
Average (9y)
$-137.73M
Historical baseline
Range
High:$703.98M
Low:$-427.65M
CAGR
+8.6%
Consistent expansion
PeriodValueChange
2024$-177.18M+8.4%
2023$-193.47M+37.5%
2022$-309.68M+27.6%
2021$-427.65M-33.4%
2020$-320.55M+9.7%
2019$-354.97M-150.4%
2018$703.98M+881.4%
2017$-90.09M+27.0%
2016$-123.42M-46.4%
2015$-84.28M-